DAVID B EISENHAURE
CIK 902744 · Chief Executive Officer · last filed 2021-01-06
DAVID B EISENHAURE is a Chief Executive Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for IPWR, was dated Jan 6, 2021. Across all open-market trades the lifetime net is +$49.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $142.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$142.2K
2
13
$49.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IPWR | Director | 23,311 | $6.10 | $142.2K | $49.9K | 10 | 2021-01-06 |
| IMPLANT SCIENCES CORP (IMX) Delisted | Director | — | — | — | $0 | 2 | 2008-12-31 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-06 | IPWR | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | IPWR | Grant (A) | — | $0 | EDGAR |
| 2019-05-02 | IPWR | Grant (A) | — | $0 | EDGAR |
| 2019-04-05 | IPWR | Disp (D) | — | $0 | EDGAR |
| 2018-01-04 | IPWR | Grant (A) | — | $0 | EDGAR |
| 2017-03-06 | IPWR | Buy (P) | +19,700 | $49.9K | EDGAR |
| 2017-01-20 | IPWR | Grant (A) | — | $0 | EDGAR |
| 2016-01-06 | IPWR | Grant (A) | — | $0 | EDGAR |
| 2014-03-24 | IPWR | Grant (A) | +3,611 | $18.1K | EDGAR |
| 2014-01-08 | IPWR | Grant (A) | +3,611 | $18.1K | EDGAR |